The American Diabetes Association has released the 2024 Standards of Care for people with Type 1 and Type 2 Diabetes. Join us as we talk with one of our favorite diabetes experts, Dr. Sue Cornell, about the major shifts in diabetes care that are omnipresent in this year's guideline updates.
 
The GameChanger
Diabetes treatment is shifting to prevention and delay. After a long period of time without many advances, we are now on the brink of changing the game in diabetes care and prevention with new drugs and technologies.
 
Host
Geoff Wall, PharmD, BCPS, FCCP, BCGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health

Susan Cornell, PharmD, CDCES, FAPhA, FADCES
Diabetes Care & Education Specialist
Midwestern University College of Pharmacy
 
Pharmacist Members, REDEEM YOUR CPE HERE!
 
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)


CPE Information
 
Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Discuss highlights of the 2024 American Diabetes Association Standards of Care Update
2. Describe the landscape of diabetes care as it shifts to prevention and delay

0.05 CEU/0.5 Hr
UAN: 0107-0000-24-050-H01-P
Initial release date: 2/5/2024
Expiration date: 2/5/2025
Additional CPE details can be found here.

Join us Tuesday, February 13th from 7-9pm for our next live course:
From A1C to Z: A Sweet Update on Diabetes Guidelines
This course will review the latest revisions to the American Diabetes Association (ADA) Standards of Care specifically highlighting the rising rates of obesity-related to diabetes, a pressing health concern affecting millions worldwide and often referred to as "diabesity". Learners will gain insights into nuances related to medication management and therapeutic decision-making for patients with diabetes. Content will provide guidance for reviewing and crafting patient-centered treatment strategies that holistically address glucose management while fostering improvements in cardio-metabolic, kidney, liver, and cognitive health for individuals grappling with diabetes and related comorbidities. 

Follow CEimpact on Social Media:
LinkedIn
Instagram